Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EC editorial

This article was originally published in The Tan Sheet

Executive Summary

Inappropriate use of emergency contraceptive pills causes less harm than some currently marketed OTCs, David Grimes, MD, Family Health International, asserts in Sept. 12 NEJM editorial expressing support for an OTC switch of the drug. Grimes points out that while intentional overdose of aspirin could result in death, such use of EC pills would only "result in nausea, vomiting or menstrual irregularity." Grimes also notes labeling instructions for ECs "are simpler than those for many products that are currently available without a prescription, including ibuprofen, chlorpheniramine maleate, cimetidine and miconazole." In further support of OTC EC availability, Grimes points out that "the same dose is used for all women...[so] it is not necessary for a physician to determine the correct" amount to take...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS094526

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel